InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: None

Thursday, 09/17/2015 8:45:53 AM

Thursday, September 17, 2015 8:45:53 AM

Post# of 40503
This guarantees double figures:

Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of its HPV Immunotherapy in The Lancet

Distinguished medical journal reports killer T cells produced by immunotherapy regress high grade cervical neoplasia and clears HPV infection


https://www.swiftpage3.com/speasapage.aspx?X=2V13NREZIIJIK0IO00W8WI

And $100+ soon!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News